Advanced Carcinoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma (NCT00794417) | Regeneron Pharmaceuticals | 2008-11-30 |
Track Advanced Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.